Tower Research Capital (TRC)’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.9K Buy
3,345
+2,151
+180% +$29K ﹤0.01% 2792
2025
Q4
$13.4K Sell
1,194
-4,061
-77% -$46.5K ﹤0.01% 3407
2025
Q3
$60.7K Sell
5,255
-1,002
-16% -$11.7K ﹤0.01% 2369
2025
Q2
$76.6K Buy
6,257
+5,083
+433% +$63.9K ﹤0.01% 2607
2025
Q1
$16.8K Sell
1,174
-6,901
-85% -$108K ﹤0.01% 3141
2024
Q4
$129K Buy
8,075
+6,714
+493% +$133K ﹤0.01% 2011
2024
Q3
$32.7K Sell
1,361
-7,551
-85% -$173K ﹤0.01% 2958
2024
Q2
$178K Buy
8,912
+4,948
+125% +$96.4K ﹤0.01% 2168
2024
Q1
$78.9K Sell
3,964
-9,241
-70% -$179K ﹤0.01% 1967
2023
Q4
$296K Buy
13,205
+10,348
+362% +$214K ﹤0.01% 1784
2023
Q3
$57.8K Buy
2,857
+47
+2% +$1.06K ﹤0.01% 2421
2023
Q2
$71.8K Buy
2,810
+1,609
+134% +$42.4K ﹤0.01% 2285
2023
Q1
$36K Sell
1,201
-1
-0.1% -$29 ﹤0.01% 2802
2022
Q4
$32K Sell
1,202
-5,155
-81% -$126K ﹤0.01% 2683
2022
Q3
$139K Buy
6,357
+4,156
+189% +$109K ﹤0.01% 2254
2022
Q2
$60K Buy
2,201
+1,639
+292% +$47.1K ﹤0.01% 2711
2022
Q1
$19K Sell
562
-867
-61% -$27.9K ﹤0.01% 3567
2021
Q4
$50K Sell
1,429
-5,155
-78% -$167K ﹤0.01% 2754
2021
Q3
$206K Sell
6,584
-10,186
-61% -$346K 0.01% 1793
2021
Q2
$610K Buy
16,770
+9,101
+119% +$376K 0.02% 1017
2021
Q1
$336K Buy
7,669
+766
+11% +$35.9K 0.01% 1579
2020
Q4
$317K Sell
6,903
-61,922
-90% -$2.58M 0.01% 1345
2020
Q3
$2.29M Buy
68,825
+50,812
+282% +$1.62M 0.03% 318
2020
Q2
$529K Buy
18,013
+17,963
+35,926% +$520K 0.02% 981
2020
Q1
$1K Sell
50
-68
-58% -$2.03K ﹤0.01% 2728
2019
Q4
$4K Sell
118
-779
-87% -$28.2K ﹤0.01% 2747
2019
Q3
$34K Sell
897
-2,377
-73% -$90.7K ﹤0.01% 2060
2019
Q2
$143K Buy
3,274
+1,384
+73% +$59.2K 0.01% 1003
2019
Q1
$81K Buy
1,890
+1,514
+403% +$67.8K ﹤0.01% 1527
2018
Q4
$17K Sell
376
-4,777
-93% -$250K ﹤0.01% 2050
2018
Q3
$353K Buy
5,153
+3,928
+321% +$253K 0.03% 670
2018
Q2
$70K Sell
1,225
-4,476
-79% -$237K ﹤0.01% 1653
2018
Q1
$262K Buy
5,701
+4,090
+254% +$194K 0.02% 756
2017
Q4
$75K Sell
1,611
-4,262
-73% -$196K 0.01% 1050
2017
Q3
$264K Buy
+5,873
New +$251K 0.02% 554
2017
Q2
Sell
-4,836
Closed -$184K 2698
2017
Q1
$184K Buy
4,836
+2,448
+103% +$95.4K 0.02% 296
2016
Q4
$88K Buy
2,388
+1,658
+227% +$59.3K 0.01% 1043
2016
Q3
$25K Sell
730
-2,469
-77% -$86.5K ﹤0.01% 1479
2016
Q2
$104K Buy
+3,199
New +$98K 0.01% 1078
2016
Q1
Sell
-680
Closed -$23K 4096
2015
Q4
$23K Buy
+680
New +$21.1K ﹤0.01% 1146
2015
Q3
Sell
-8,662
Closed -$351K 3977
2015
Q2
$351K Buy
8,662
+8,334
+2,541% +$374K 0.03% 199
2015
Q1
$16K Sell
328
-1,478
-82% -$68.5K ﹤0.01% 2417
2014
Q4
$82K Buy
+1,806
New +$71K 0.01% 782

Other funds holding AVNS